Copyright © 2004 The American Society of Human Genetics. All rights reserved.
The American Journal of Human Genetics, Volume 74, Issue 6, 1309-1313, 1 June 2004
doi:10.1086/421528
Report
R.S. Savkur1, A.V. Philips1, T.A. Cooper1, J.C. Dalton2, M.L. Moseley2, 4, L.P.W. Ranum2, 4 and J.W. Day2, 3,
, 
1 Department of Pathology, Baylor University, Houston
2 Institute of Human Genetics, University of Minnesota, Minneapolis
3 Department of Neurology, University of Minnesota, Minneapolis
4 Department of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis
Address for correspondence and reprints: Dr. John W. Day, Professor of Neurology, Institute of Human Genetics, MMC 206, University of Minnesota, 420 Delaware Street, Minneapolis, MN 55455.Abstract
Myotonic dystrophy (DM) is caused by either an untranslated CTG expansion in the 3′ untranslated region of the DMPK gene on chromosome 19 (dystrophia myotonica type 1 [DM1]), or an untranslated CCTG tetranucleotide repeat expansion in intron 1 of the ZNF9 gene on chromosome 3 (dystrophia myotonica type 2 [DM2]). RNA-binding proteins adhere to transcripts of the repeat expansions that accumulate in the nucleus, and a trans-dominant dysregulation of pre-mRNA alternative splicing has been demonstrated for several genes. In muscle from patients with DM1, altered insulin-receptor splicing to the nonmuscle isoform corresponds to the insulin insensitivity and diabetes that are part of the DM phenotype; because of insulin-receptor species differences, this effect is not seen in mouse models of the disease. We now demonstrate that comparable splicing abnormalities occur in DM2 muscle prior to the development of muscle histopathology, thus demonstrating an early pathogenic effect of RNA expansions.
| Myotonic Dystrophy: RNA Pathogenesis Comes into Focus The American Journal of Human Genetics, Volume 74, Issue 5, 1 May 2004, Pages 793-804 Laura P.W. Ranum and John W. Day Abstract Myotonic dystrophy (DM)—the most common form of muscular dystrophy in adults, affecting 1/8,000 individuals—is a dominantly inherited disorder with a peculiar and rare pattern of multisystemic clinical features affecting skeletal muscle, the heart, the eye, and the endocrine system. Two genetic loci have been associated with the DM phenotype: DM1, on chromosome 19, and DM2, on chromosome 3. In 1992, the mutation responsible for DM1 was identified as a CTG expansion located in the 3′ untranslated region of the dystrophia myotonica-protein kinase gene (DMPK). How this untranslated CTG expansion causes myotonic dystrophy type 1(DM1) has been controversial. The recent discovery that myotonic dystrophy type 2 (DM2) is caused by an untranslated CCTG expansion, along with other discoveries on DM1 pathogenesis, indicate that the clinical features common to both diseases are caused by a gain-of-function RNA mechanism in which the CUG and CCUG repeats alter cellular function, including alternative splicing of various genes. We discuss the pathogenic mechanisms that have been proposed for the myotonic dystrophies, the clinical and molecular features of DM1 and DM2, and the characterization of murine and cell-culture models that have been generated to better understand these diseases. Abstract | | |
| Intergenerational Instability of the Expanded CTG Repeat in the DMPK Gene: Studies in Human Gametes and Preimplantation Embryos The American Journal of Human Genetics, Volume 75, Issue 2, 1 August 2004, Pages 325-329 Nele De Temmerman, Karen Sermon, Sara Seneca, Martine De Rycke, Pierre Hilven, Willy Lissens, André Van Steirteghem and Inge Liebaers Abstract The CTG repeat at the 3′ untranslated region of the dystrophia myotonica protein kinase (DMPK) gene shows marked intergenerational and somatic instability in patients with myotonic dystrophy (DM1), when the repeat is expanded to more than ∼55 repeats. Intensive research has yielded some insights into the timing and mechanism of these intergenerational changes: (1) increases in expansion sizes occur during gametogenesis but probably not during meiosis, (2) the marked somatic mosaicism becomes apparent from the 2nd trimester of development onward and increases during adult life, and (3) DNA repair mechanisms are involved. We have performed preimplantation genetic diagnosis for DM1 since 1995, which has given us the unique opportunity to study the expanded CTG repeat in affected embryos and in gametes from affected patients. We were able to demonstrate significant increases in the number of repeats in embryos from female patients with DM1 and in their immature and mature oocytes, whereas, in spermatozoa and embryos from male patients with DM1, smaller increases were detected. These data are in concordance with data on other tissues from adults and fetuses and fill a gap in our knowledge of the behavior of CTG triplet expansions in DM1. Abstract | | |